1. Wu, Yahan, Zhou, Liping, Liu, Hongyu, Liang, Dandan, Chen, Yi-Han. 2020. LRP6 downregulation promotes cardiomyocyte proliferation and heart regeneration. In Cell research, 31, 450-462. doi:10.1038/s41422-020-00411-7. https://pubmed.ncbi.nlm.nih.gov/32973339/
2. Go, Gwang-Woong, Mani, Arya. 2012. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. In The Yale journal of biology and medicine, 85, 19-28. doi:. https://pubmed.ncbi.nlm.nih.gov/22461740/
3. Acebron, Sergio P, Niehrs, Christof. 2016. β-Catenin-Independent Roles of Wnt/LRP6 Signaling. In Trends in cell biology, 26, 956-967. doi:10.1016/j.tcb.2016.07.009. https://pubmed.ncbi.nlm.nih.gov/27568239/
4. Kumar, Dinesh, Narang, Rajiv, Saluja, Daman, Srivastava, Kamna. 2022. Functional Association of miR-133b and miR-21 Through Novel Gene Targets ATG5, LRP6 and SGPP1 in Coronary Artery Disease. In Molecular diagnosis & therapy, 26, 655-664. doi:10.1007/s40291-022-00615-0. https://pubmed.ncbi.nlm.nih.gov/36197604/
5. Labbé, Pauline, Thorin, Eric. 2019. Therapeutic Targeting of LRP6 in Cardiovascular Diseases: Challenging But Not Wnt-Possible! In The Canadian journal of cardiology, 35, 1567-1575. doi:10.1016/j.cjca.2019.06.030. https://pubmed.ncbi.nlm.nih.gov/31679626/
6. Lee, Yejin, Chae, Wonseon, Kim, Youn Jung, Kim, Jung-Wook. 2022. Novel LRP6 Mutations Causing Non-Syndromic Oligodontia. In Journal of personalized medicine, 12, . doi:10.3390/jpm12091401. https://pubmed.ncbi.nlm.nih.gov/36143186/
7. Shay, Timothy F, Jang, Seongmin, Brittain, Tyler J, Chou, Tsui-Fen, Gradinaru, Viviana. 2024. Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder. In Nature communications, 15, 7853. doi:10.1038/s41467-024-52149-0. https://pubmed.ncbi.nlm.nih.gov/39245720/